India pharmaceutical sector

India pharmaceutical sector

Ebrima Sagnia prays at the graveside of his 3-year-old son Lamin in Old Yundum, Gambia, 1 November, 2022. Lamin died of Acute Kidney Injury in September 2022. In October, the deaths of more than 70 Gambian children from Acute Kidney Injury were linked by global health officials to cough syrups made in India and contaminated with ethylene glycol and diethylene glycol. REUTERS/Edward McAllister

India considers policy change after cough syrup deaths

Photo: Collected

Global investors, private equity firms triple investments in India's API sector